HLA-B*5701 Genotyping for Abacavir Prescription: Re-Examination of its Cost-Effectiveness in Singapore

被引：0
|
作者：
Goh, Kang Shiong [1 ]
Kapoor, Ritika [2 ]
Lee, Cheng Chuan [3 ]
Ng, Carol Y. L. [4 ]
Leong, Khai Pang [3 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[3] Tan Tock Seng Hosp, Dept Rheumatol Allergy & Immunol, Singapore, Singapore
[4] Tan Tock Seng Hosp, Clin Immunol Lab, Singapore, Singapore
来源：
ANNALS ACADEMY OF MEDICINE SINGAPORE | 2019年 / 48卷 / 04期
关键词：
HYPERSENSITIVITY REACTIONS; HIV;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 138
页数：6
相关论文
共 46 条
  • [1] Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
    Hughes, DA
    Vilar, FJ
    Ward, CC
    Alfirevic, A
    Park, BK
    Pirmohamed, M
    [J]. PHARMACOGENETICS, 2004, 14 (06): : 335 - 342
  • [2] Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription: clinically useful but is it cost-effective in Singapore?
    Kapoor, Ritika
    Martinez-Vega, Rosario
    Dong, Di
    Tan, Sharlene Yanying
    Leo, Yee-Sin
    Lee, Cheng-Chuan
    Sung, Cynthia
    Oon-Tek Ng
    Archuleta, Sophia
    Teo, Yik-Ying
    [J]. PHARMACOGENETICS AND GENOMICS, 2015, 25 (02): : 60 - 72
  • [3] Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV plus patients in Spain
    Nieves Calatrava, Diana
    de la Calle-Martin, Oscar
    Iribarren-Loyarte, Jose A.
    Rivero-Roman, Antonio
    Garcia-Bujalance, Laura
    Perez-Escolano, Isabel
    Brosa-Riestra, Max
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2010, 28 (09): : 590 - 595
  • [4] HLA-B*5701 screening prior to abacavir prescription: Clinical and laboratory aspects
    Nolan, David
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (03) : 153 - 165
  • [5] Implementation of HLA-B*5701 genetic screening prior to abacavir prescription in Georgia
    Dvali, N.
    Chkhartishvili, N.
    Sharvadze, L.
    Dzigua, L.
    Karchava, M.
    Gatserelia, L.
    Tsertsvadze, T.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E244 - E245
  • [6] Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
    Dong, Di
    Sung, Cynthia
    Finkelstein, Eric Andrew
    [J]. NEUROLOGY, 2012, 79 (12) : 1259 - 1267
  • [7] COST-EFFECTIVENESS OF HLA-B*1502 GENOTYPING IN ADULT PATIENTS WITH NEWLY DIAGNOSED EPILEPSY IN SINGAPORE
    Hung, Shuen-Iu
    Chung, Wen-Hung
    [J]. NEUROLOGY, 2013, 80 (17) : 1621 - 1621
  • [8] The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
    Schackman, Bruce R.
    Scott, Callie A.
    Walensky, Rochelle P.
    Losina, Elena
    Freedberg, Kenneth A.
    Sax, Paul E.
    [J]. AIDS, 2008, 22 (15) : 2025 - 2033
  • [9] Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore
    Dong, Di
    Tan-Koi, Wei-Chuen
    Teng, Gim Gee
    Finkelstein, Eric
    Sung, Cynthia
    [J]. PHARMACOGENOMICS, 2015, 16 (16) : 1781 - 1793
  • [10] Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain (vol 28, pg 590, 2011)
    Nieves Calatrava, Diana
    de la Calle-Martin, Oscar
    Iribarren-Loyarte, Jose A.
    Rivero-Roman, Antonio
    Garcia-Bujalance, Laura
    Perez-Escolano, Isabel
    Brosa-Riestra, Max
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (06): : 356 - 356
12345